Regulatory News :
“We are confident about the development of the Chinese market, which is expected to accelerate once we gain regulatory approval for Cellvizio 100 and the AQ-Flex 19 probe in the characterization of pancreatic cysts” Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary optical biopsy platform, announces a strong presence at the annual CCDD 2014 conference on digestive endoscopy held in Jinan, China, from October 10 to 12.
Help employers find you! Check out all the jobs and post your resume.
